Innoviva, Inc. (INVA) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Innoviva, Inc. (INVA) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

INVA

Market Closed

Innoviva, Inc.

NASDAQHealthcare Biotechnology

159 employees

CEO: Pavel Raifeld

Founded: 2004

$21.44

+$0.00(+NaN%)

Market Cap

1.58B

Beta

0.34

52W Range

N/A

Dividend Yield

4.66%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

72.3%

-4.5%

CAGR: -5.9%

Profit after direct costs

Operating Margin

38.5%

-1.9%

CAGR: -18.7%

Core business profitability

Net Margin

63.8%

1059.2%

CAGR: 0.5%

Bottom line profitability

Revenue Growth

18.5%

YoY

CAGR: 2.1%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how INVA allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

72.3%

$307.52M

Operating Margin

38.5%

$163.75M

Net Margin

63.8%

$271.17M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	391.87M	331.34M	310.46M	358.71M	425.13M	18.5%
Cost of Revenue	—	(13.79M)	(42.64M)	(36.60M)	(117.61M)	221.4%
Gross Profit	391.87M	317.55M	267.82M	322.11M	307.52M	-4.5%
Operating Expenses
Research & Development	(576.00K)	(41.43M)	(33.92M)	(13.65M)	(30.60M)	124.1%
Selling, General & Administrative	(16.19M)	(63.54M)	(98.23M)	(115.69M)	(113.17M)	-2.2%
Depreciation & Amortization	(13.83M)	(5.58M)	(21.78M)	(25.90M)	(40.23M)	55.3%
Operating Income (EBIT)	375.10M	207.00M	113.89M	166.87M	163.75M	-1.9%
Non-Operating Items
Interest Income	1.84M	6.37M	15.82M	19.14M	21.09M	10.2%
Interest Expense	(19.07M)	(15.79M)	(19.16M)	(22.21M)	(16.70M)	-24.8%
Other Income/Expenses (Net)	70.17M	79.95M	80.21M	-129.48M	163.12M	-226.0%
Income Before Tax	445.28M	286.95M	194.10M	37.39M	326.86M	774.2%
Income Tax Expense	(76.44M)	(66.69M)	(14.38M)	(14.00M)	(55.70M)	297.9%
Net Income	265.85M	213.92M	179.72M	23.39M	271.17M	1059.2%
Per Share Metrics
Earnings Per Share (Basic)	$3	$3	$3	$0	$4	986.5%
Weighted Avg Shares Outstanding	82.06M	69.64M	65.44M	62.73M	67.39M	7.4%
Weighted Avg Shares Outstanding (Diluted)	94.31M	95.25M	86.88M	74.19M	84.76M	14.3%
EBITDA	478.18M	308.32M	235.04M	85.50M	383.79M	348.9%

Explore INVA

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

INVA in the Healthcare

Small Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →